Sharps Technology Long Term Debt 2022-2025 | STSS

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Sharps Technology long term debt from 2022 to 2025. Long term debt can be defined as the sum of all long term debt fields.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Sharps Technology long term debt from 2022 to 2025. Long term debt can be defined as the sum of all long term debt fields.

Related Stocks
Company Name	Market Cap
Abbott Laboratories (ABT)	$228.6B
Boston Scientific (BSX)	$156.7B
Stryker (SYK)	$149B
EssilorLuxottica (ESLOY)	$142.5B
Medtronic (MDT)	$118B
Lonza Group Ag (LZAGY)	$49.9B
Haleon (HLN)	$43.5B
ResMed (RMD)	$40.3B
Agilent Technologies (A)	$35.5B
GE HealthCare Technologies (GEHC)	$33.7B
Terumo (TRUMY)	$26.8B
Koninklijke Philips (PHG)	$26.6B
Insulet (PODD)	$23.8B
Zimmer Biomet Holdings (ZBH)	$20.8B
Smith & Nephew SNATS (SNN)	$16.3B
Baxter (BAX)	$12.5B
Sunny Optical Technology (SNPTF)	$10.8B
Demant (WILYY)	$8.1B
Bio-Rad Laboratories (BIO)	$7.9B
Lantheus Holdings (LNTH)	$3.8B
Envista Holdings (NVST)	$3.5B
Shandong Weigao Medical Polymer (SHWGF)	$3.5B
Prestige Consumer Healthcare (PBH)	$3.3B
Perrigo (PRGO)	$3.3B
ICU Medical (ICUI)	$3.1B
Haemonetics (HAE)	$2.6B
Curaleaf Holdings (CURLF)	$2.3B
Acuren (TIC)	$2.2B
LeMaitre Vascular (LMAT)	$2.2B
QuidelOrtho (QDEL)	$1.9B